08/04/2021 08:37
European countries should make their own decisions about how to handle the risk of rare blood clots from AstraZeneca’s COVID-19 vaccine, based on prevailing infection rates and the availability of alternative vaccines, the EU drugs regulator said on Wednesday.
Πηγή: Reuters